The City opened 24,000 MPV vaccination appointments as of Friday, October 28, as the city begins to transition away from pop-up.
Mass vaccination sites to existing community care infrastructure. With more than 146,000 first and second doses administered, cases have been in decline for months. In addition, community partners have dramatically reduced the spread through referrals to care, public health messaging, and other successful interventions.
“We have widespread access to MPV vaccination, have slowed transmission dramatically, and have overcome early challenges due to the successful partnership between the City and community members,” said Health Commissioner Dr. Ashwin Vasan. “Together, the story of this response will ultimately be one of confidence in public health, in the broadest sense, involving a robust collaborative effort between our public sector and community leaders and organizations. We’re grateful for the advocacy by LGBTQ+ New Yorkers as well as the ongoing support and tireless work of all our community partners. We will continue to make vaccines available as widely as possible, so New Yorkers can protect themselves and each other.”
“The City’s public health system is proud to continue providing vaccinations, testing and treatment for MPV patients at its hospital-based ambulatory and PRIDE clinics,” said Dr. Andrew B. Wallach, Ambulatory Care Chief Medical Officer at NYC Health + Hospitals. “Together, we have risen to the challenge this virus presented, ensuring that New Yorkers are protected and those who identify as members of the LGBTQIA+ communities receive the culturally responsive, gender-affirming care they deserve.”
Daily cases have fallen from more than 70 per day in July to around 5 per day in October.
As a result, the MPV vaccination effort will transition from city-operated mass vaccination sites into existing clinics and other community providers. Many of the sites will be listed at vax4nyc.nyc.gov/monkeypox.
The Health Department’s sexual health clinics in Fort Greene, Jamaica, Chelsea and Morrisania will begin offering MPV vaccine on Nov. 14. Additionally, NYC Health + Hospitals will begin providing vaccinations to patients at its 11 acute ambulatory clinics and 5 acute PRIDE clinics (co-located at Metropolitan, Bellevue, Lincoln, Woodhull, Jacobi hospitals) on November 14. Additional sites will launch on November 14 at Vanderbilt.
As appointments at mass vaccination sites have dwindled in recent weeks, Times Square, Long Island City, the Livonia in Brooklyn, the Tremont vaccination site in the Bronx, and a location at the Health Department’s Central Harlem community clinic will close operations in mid-November. The last day of shots at Central Harlem and Tremont will be November 10. Long Island City, Livonia and Time Square will close on November 15. NYC Health + Hospitals and Gotham Health will also close mass vaccination sites November 10 at:
- NYC Health + Hospitals/Gouverneur
- NYC Health + Hospitals/Kings
- NYC Health + Hospitals/Lincoln
- NYC Health + Hospitals/Gotham Health, Vanderbilt
New Yorkers who received their first doses are strongly advised to get their second doses 28 days after their first. Walk-in appointments are available. To find a location where vaccine is available go to the NYC Vaccine Finder.
New Yorkers seeking care for suspected MPV should call their healthcare provider immediately. For those who do not have one, they can call 311 to get connected to an NYC Health + Hospitals location or to access NYC Health + Hospital’s Virtual ExpressCare. New Yorkers can also visit the NYC Health Map to find a nearby provider. Care is available in New York City regardless of immigration status, insurance coverage, or ability to pay.
For more on MPV, go to: https://www1.nyc.gov/site/doh/health/health-topics/monkeypox.page
Become a Harlem Insider!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
